After univariate and subsequent multivariate analysis, only LCN2 expression was found to be negatively associated with overall survival (OS) of patients with CCA (p < 0.001, relative risk, 3.615 (1.721–7.592)) (Supplemental Table 2 and Fig. 6E). Here, LCN2 is linked to cholangiocarcinoma.